主动脉瓣狭窄合并冠心病的治疗进展OACSTPCD
Advance in the treatment of aortic stenosis with coronary artery disease
重度主动脉瓣狭窄(AS)的治疗在近十年获得了很大的进展,逐步进入微创治疗的时代.随着经导管主动脉瓣置换在我国越来越多地开展,人们对于重度AS的管理和治疗有了新的认识,AS患者中合并冠心病(CAD)的数量很多,给治疗带来了难度,本文针对AS合并CAD患者的评估、管理、治疗方面的经验及存在问题进行综述,期望未来有更多研究支持AS合并CAD的介入治疗.
There is a great progress for the treatment of severe aortic stenosis(AS)in the last decade,gradually entering the era of minimally invasive treatment.With the growing development of the technology of transcatheter aortic valve replacement in China,people have a new perspective on the management and treatment of severe AS.A large number of AS patients are combined with coronary artery disease(CAD),which bring obstacles to the treatment.Therefore,this paper summarizes the experience and existing problems in the evaluation,management and treatment of AS patients with CAD.It is expected that there will be more studies support the interventional therapy of AS combined with CAD in the future.
方震;纪军;骆莹莹
225000 扬州,江苏省苏北人民医院(扬州大学临床医学院)心内科225000 扬州,江苏省苏北人民医院(扬州大学临床医学院)心功能检查科
重度主动脉瓣狭窄经导管主动脉瓣置换冠心病介入治疗
Severe aortic stenosisTranscatheter aortic valve replacementCoronary artery diseaseInterventional treatment
《心脑血管病防治》 2024 (004)
41-44 / 4
评论